rs11695910 - ERBB4 - LINC01878
Magnitude 2.2 · 1 study on file
Reported associations
-
New role of fat-free mass in cancer risk linked with genetic predisposition - Unknown journal (n.d.) · Unknown authors · PubMed 38538606
ABSTRACT: Cancer risk is associated with the widely debated measure body mass index (BMI). Fat mass and fat-free mass measurements from bioelectrical impedance may further clarify this association. The UK Biobank is a rare resource in which bioelectrical impedance and BMI data was collected on ~ 500,000 individuals. Using this dataset, a comprehensive analysis using regression, principal component and genome-wide genetic association, provided multiple levels of evidence that increasing whole body fat (WBFM) and fat-free mass (WBFFM) are both associated with increased post-menopausal breast cancer risk, and colorectal cancer risk in men. WBFM was inversely associated with prostate cancer. We also identified rs615029[T] and rs1485995[G] as associated in independent analyses with both PMB
Auto-generated from study metadata. AI-synthesised commentary is added when this entry is regenerated through content-service's LLM mode.
Lifestyle context
Concrete actions anchored to the cited research. We do not prescribe, we describe.
Discuss with your doctor
-
genetic breast cancer risk assessment Moderate
rs11695910 G allele in ERBB4 associates with approximately 10.5% increased postmenopausal breast cancer risk
Discuss family history, genetic testing options, and screening recommendations with your healthcare provider
Screening
-
mammography screening for breast cancer Moderate
Carriers of genetic risk variants for postmenopausal breast cancer may benefit from more intensive screening per medical guidelines
Work with healthcare provider to establish appropriate screening intervals based on genetic risk stratification